Rinvoq LQ Interactions
There are 616 drugs known to interact with Rinvoq LQ (upadacitinib), along with 9 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 382 are major, 224 are moderate, and 10 are minor.
- View all 616 medications that may interact with Rinvoq LQ
- View Rinvoq LQ alcohol/food interactions (2)
- View Rinvoq LQ disease interactions (9)
Most frequently checked interactions
View interaction reports for Rinvoq LQ (upadacitinib) and the medicines listed below.
- acarbose
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Addyi (flibanserin)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- albuterol
- Alhemo (concizumab)
- Allegra (fexofenadine)
- Altuviiio (antihemophilic factor)
- Alyftrek (deutivacaftor / tezacaftor / vanzacaftor)
- ambrisentan
- amitriptyline
- Amondys 45 (casimersen)
- amoxicillin / clavulanate
- Amvuttra (vutrisiran)
- Andembry (garadacimab)
- apremilast
- Arava (leflunomide)
- Astepro (azelastine nasal)
- atomoxetine
- atorvastatin
- Attruby (acoramidis)
- Cymbalta (duloxetine)
- Humira (adalimumab)
- montelukast
- Nurtec ODT (rimegepant)
- Qulipta (atogepant)
- Vitamin D3 (cholecalciferol)
Rinvoq LQ alcohol/food interactions
There are 2 alcohol/food interactions with Rinvoq LQ (upadacitinib).
Rinvoq LQ disease interactions
There are 9 disease interactions with Rinvoq LQ (upadacitinib) which include:
- cardiovascular risk
- malignancy
- thrombosis
- infections
- cytopenias
- gastrointestinal perforation
- hepatic impairment
- hyperlipidemia
- vaccination
Report options
More about Rinvoq LQ (upadacitinib)
- Compare alternatives
- Pricing & coupons
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antirheumatics
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Otezla
Otezla (apremilast) is used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers ...
Cosentyx
Cosentyx (secukinumab) is used to treat plaque psoriasis, psoriatic arthritis, ankylosing ...
Humira
Humira is a tumor necrosis factor blocker used to treat many inflammatory conditions in adults ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Tremfya
Tremfya (guselkumab) injection is used to treat plaque psoriasis, psoriatic arthritis, ulcerative ...
Enbrel
Enbrel is used to treat rheumatoid arthritis, ankylosing spondylitis, and psoriasis. Learn about ...
Remicade
Remicade is used to treat rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and Crohn's ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
